ASLAN Pharmaceuticals OverviewASLAN Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for ASLN.
Quarterly Other Income/Expense
$36026.00
↑ 103.59% YoY
As of Mar 31, 2024
Annual Other Income/Expense (TTM)
$2.88M
↑ 185.59% YoY
Trailing 12 months ending Mar 31, 2024